Evaluation of interleukin 8 and interleukin 10 cytokines in liquid based cervical cytology samples
- PMID: 31303919
- PMCID: PMC6607241
- DOI: 10.11604/pamj.2019.32.148.16314
Evaluation of interleukin 8 and interleukin 10 cytokines in liquid based cervical cytology samples
Abstract
Introduction: inflammatory cytokines have been associated with various cancers, including cervical cancers. Interpreting cytokine expression in liquid based cervical samples is quite challenging. This study is aimed at evaluating the levels of interleukin 8 and 10 in liquid based cervical samples.
Methods: this is a descriptive analytical study carried out on eighty five (85) subjects aged between 23 and 68 years. Cervical samples were collected in liquid based medium and smears later examined after staining with Papanicolaou technique. These were categorized into low grade intra-epithelial lesion/malignancy, high grade intraepithelial lesion/malignancy according to the degree of dyskaryosis. Concentrations of interleukin 8 and interleukin 10 in the samples were determined by enzyme linked immunosorbent assay.
Results: the mean age, standard deviation (SD) of the study subjects were 40.6 (7.8) years. A total number of 79 females (92.9%) were negative for intra-epithelial lesion/malignancy (NILM), while 4 (4.71%) and 2 (2.35%) were positive for low grade intra-epithelial lesion/malignancy (LILM) and high grade intra-epithelial lesion (HILM) respectively. While mean levels of interleukin 8 increased with the degree of malignancy, (107.27 ± 11.88pg/ml) in LILM, (114.80 ± 2.12pg/ml) in HILM when compared with NILM (88.39 ± 18.06pg/ml), (f = 0.700, p = 0.018); the mean levels of interleukin 10 was comparable between these groups (p ≥ 0.05). Pearson correlation coefficient analysis showed a negative association between interleukin 8 and interleukin 10 (r = -1.999, p = 0.000) in LILM.
Conclusion: interleukin 8 cytokines in cervical cancer is associated with the degree of malignancy. Possible anti-inflammatory effect of interleukin 10 was not observed.
Keywords: Cytokines; cervical cancer; inflammation.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.J Low Genit Tract Dis. 2011 Apr;15(2):105-9. doi: 10.1097/LGT.0b013e3181f41ee4. J Low Genit Tract Dis. 2011. PMID: 21317806
-
The interpretation of high-grade squamous intraepithelial lesion on anal cytology: a comparative analysis with the cervical Papanicolaou test.J Am Soc Cytopathol. 2020 Nov-Dec;9(6):540-549. doi: 10.1016/j.jasc.2020.07.132. Epub 2020 Jul 22. J Am Soc Cytopathol. 2020. PMID: 32800528
-
Colposcopy in women with a normal Papanicolaou smear.Natl Med J India. 1994 Sep-Oct;7(5):208-9. Natl Med J India. 1994. PMID: 7827598
-
Role of Ancillary Techniques in Cervical Biopsy and Endocervical Curettage Specimens as Follow-Up to Papanicolaou Test Results Indicating a Diagnosis of Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion, or High-Grade Squamous Intraepithelial Lesion.Acta Cytol. 2020;64(1-2):155-165. doi: 10.1159/000498888. Epub 2019 Apr 12. Acta Cytol. 2020. PMID: 30982025 Review.
-
Negative computer-imaged ThinPrep Pap test and positive hybrid capture2 HPV co-testing results: A quality assurance review.Diagn Cytopathol. 2015 Sep;43(9):763-9. doi: 10.1002/dc.23303. Epub 2015 Jul 15. Diagn Cytopathol. 2015. PMID: 26173579 Review.
Cited by
-
Relationship between Monoclonal Gammopathy of undetermined significance and multiple myeloma via online database analysis.Pak J Med Sci. 2023 May-Jun;39(3):715-720. doi: 10.12669/pjms.39.3.7206. Pak J Med Sci. 2023. PMID: 37250588 Free PMC article.
-
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk.Life (Basel). 2025 Jan 21;15(2):135. doi: 10.3390/life15020135. Life (Basel). 2025. PMID: 40003544 Free PMC article.
-
miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8.Mol Med Rep. 2021 May;23(5):322. doi: 10.3892/mmr.2021.11961. Epub 2021 Mar 24. Mol Med Rep. 2021. PMID: 33760117 Free PMC article.
-
Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer.Wien Med Wochenschr. 2023 Mar;173(3-4):57-61. doi: 10.1007/s10354-021-00907-w. Epub 2022 Jan 18. Wien Med Wochenschr. 2023. PMID: 35041104 English.
References
-
- Murooka TT, Ward SE, Fish EN. Chemokines and Cancer. Cancer Treat Res. 2005;126:15–44. - PubMed
-
- Christopher Dolinsky. “Cervical Cancer: The Basics.”. Abramson Cancer Center of the University of Pennsylvania; 2007. OncoLink.
-
- Lowe JS, Anderson Peter G, Stevens Alan. Stevens & Lowe's human histology. Fourth edition. Philadelphia, PA: Elsevier/Mosby; 2015.
-
- Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clinical Science. 2006;110(5):525–541. - PubMed